Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Akero Therapeutics Inc (NASDAQ: AKRO) closed the day trading at $38.14 down -1.88% from the previous closing price of $38.87. In other words, the price has decreased by -$1.88 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
For a better understanding of AKRO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.80 and its Current Ratio is at 16.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2025, Upgraded its rating to Buy and sets its target price to $63 from $35 previously.
On January 27, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $50 to $72.
On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.Citigroup initiated its Buy rating on November 18, 2024, with a $65 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 15 ’25 when Yale Catriona sold 10,000 shares for $39.30 per share. The transaction valued at 392,978 led to the insider holds 95,034 shares of the business.
CATRIONA YALE bought 30,000 shares of AKRO for $1,136,400 on May 15 ’25. On May 12 ’25, another insider, Cheng Andrew, who serves as the President and CEO of the company, sold 30,000 shares for $41.48 each. As a result, the insider received 1,244,455 and left with 594,324 shares of the company.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $17.86. The 50-Day Moving Average of the stock is -7.28%, while the 200-Day Moving Average is calculated to be 9.92%.
Shares Statistics:
A total of 79.67M shares are outstanding, with a floating share count of 71.21M. Insiders hold about 10.67% of the company’s shares, while institutions hold 101.94% stake in the company.
